US2018250422A1PendingUtilityA1

Methods of treating neurodegenerative disorders

51
Assignee: UNIV NEW YORK STATE RES FOUNDPriority: Aug 4, 2014Filed: May 15, 2018Published: Sep 6, 2018
Est. expiryAug 4, 2034(~7.9 yrs left)· nominal 20-yr term from priority
Inventors:Victor L. ArvanianJoel M. Levine
A61K 38/185C12N 2750/14133C12N 7/00A61K 48/005C12Y 402/02004C12N 2750/14143A61K 38/51A61K 35/76A61K 9/0085C07K 16/44C12N 15/86A61K 48/00A61K 39/3955A61K 2039/54A61K 2039/525
51
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present disclosure is directed to adeno -associated viral vector monoclonal antibody constructs and compositions thereof, methods of improving locomotor function after spinal cord injury, methods of treating neurodegenerative diseases.

Claims

exact text as granted — not AI-modified
1 .- 9 . (canceled) 
     
     
         10 . A method of treating neurodegenerative disease in a subject in need thereof comprising the administration of at least one adeno-associated virus selected from the group consisting of AAV-rh10 and AAV-hu11 and a pharmaceutically acceptable carrier. 
     
     
         13 . (canceled)

Join the waitlist — get patent alerts

Track US2018250422A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.